CXA-10
- Generic Name
- CXA-10
- Drug Type
- Small Molecule
- Chemical Formula
- C18H33NO4
- CAS Number
- 875685-46-4
- Unique Ingredient Identifier
- 1N19AGY57Y
- Background
CXA-10 is under investigation in clinical trial NCT03422510 (FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)).
Study of CXA-10 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Acute Kidney Injury (Nontraumatic)
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-04-30
- Last Posted Date
- 2018-02-01
- Lead Sponsor
- Complexa, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02127190
- Locations
- 🇺🇸
Jasper Clinical Research & Development, Inc., Kalamazoo, Michigan, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath